Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

Ren Yamada · SciRah

Researcher profile · Semantic Scholar

Ren Yamada

Share profile

Ren Yamada — researcher profile on SciRah

h-index: 14
Works: 39
Citations: 529

Most-cited papers

Tenofovir–disoproxil–fumarate modulates lipid metabolism via hepatic CD36/PPAR-alpha activation in hepatitis B virus infection
Kazuharu Suzuki, G. Suda, Yoshiya Yamamoto, Ken Furuya +19 more
2020Journal of gastroenterology56 citations
Semantic Scholar
Prevalence, clinical course, and predictive factors of immune checkpoint inhibitor monotherapy‐associated hepatitis in Japan
Takashi Kitagataya, G. Suda, K. Nagashima, T. Katsurada +24 more
2020Journal of Gastroenterology and Hepatology43 citations Open access
Semantic Scholar
Effect of switching from tenofovir disoproxil fumarate to tenofovir alafenamide on lipid profiles in patients with hepatitis B
Kazuharu Suzuki, G. Suda, Yoshiya Yamamoto, S. Abiko +16 more
2022PLoS ONE41 citations Open access
Semantic Scholar
Lenvatinib suppresses cancer stem-like cells in HCC by inhibiting FGFR 1-3 signaling, but not FGFR4 signaling.
T. Shigesawa, Osamu Maehara, G. Suda, M. Natsuizaka +19 more
2020Carcinogenesis37 citations Open access
Semantic Scholar
Early response and safety of atezolizumab plus bevacizumab for unresectable hepatocellular carcinoma in patients who do not meet IMbrave150 eligibility criteria
T. Sho, G. Suda, K. Ogawa, M. Kimura +23 more
2021Hepatology Research34 citations
Semantic Scholar
Low Baseline CXCL9 Predicts Early Progressive Disease in Unresectable HCC with Atezolizumab Plus Bevacizumab Treatment
Shunichi Hosoda, G. Suda, T. Sho, K. Ogawa +25 more
2022Liver Cancer25 citations Open access
Semantic Scholar
High serum angiopoietin‐2 level predicts non‐regression of liver stiffness measurement‐based liver fibrosis stage after direct‐acting antiviral therapy for hepatitis C
N. Kawagishi, G. Suda, M. Kimura, Osamu Maehara +16 more
2020Hepatology Research22 citations Open access
Semantic Scholar
Prediction of hepatocellular carcinoma using age and liver stiffness on transient elastography after hepatitis C virus eradication
M. Nakai, Yoshiya Yamamoto, Masaru Baba, G. Suda +12 more
2022Scientific Reports21 citations Open access
Semantic Scholar
Prophylactic tenofovir alafenamide for hepatitis B virus reactivation and reactivation‐related hepatitis
G. Suda, Masaru Baba, Yoshiya Yamamoto, T. Sho +26 more
2023Journal of Medical Virology20 citations
Semantic Scholar
Baseline angiopoietin‐2 and FGF19 levels predict treatment response in patients receiving multikinase inhibitors for hepatocellular carcinoma
T. Shigesawa, G. Suda, M. Kimura, Tomoe Shimazaki +14 more
2020JGH Open18 citations Open access
Semantic Scholar
Efficacy and Safety of Durvalumab/Tremelimumab in Unresectable Hepatocellular Carcinoma as Immune Checkpoint Inhibitor Rechallenge Following Atezolizumab/Bevacizumab Treatment
T. Sho, G. Suda, M. Ohara, R. Kohya +18 more
2024Targeted oncology17 citations
Semantic Scholar
Efficacy and Effect on Liver Functional Reserve of Atezolizumab and Bevacizumab for Unresectable Hepatocellular Carcinoma in Patients Who Do Not Meet Eligibility Criteria of IMbrave150
T. Sho, G. Suda, Yoshiya Yamamoto, Ken Furuya +25 more
2022Cancers17 citations Open access
Semantic Scholar
Baseline elevated serum angiopoietin-2 predicts long-term non-regression of liver fibrosis after direct-acting antiviral therapy for hepatitis C
N. Kawagishi, G. Suda, M. Kimura, Osamu Maehara +15 more
2021Scientific Reports16 citations Open access
Semantic Scholar
Characteristics and Lenvatinib Treatment Response of Unresectable Hepatocellular Carcinoma with Iso-High Intensity in the Hepatobiliary Phase of EOB-MRI
A. Kubo, G. Suda, M. Kimura, Osamu Maehara +14 more
2021Cancers14 citations Open access
Semantic Scholar
Changes in Serum Growth Factors during Lenvatinib Predict the Post Progressive Survival in Patients with Unresectable Hepatocellular Carcinoma
Zi-Jian Yang, G. Suda, Osamu Maehara, M. Ohara +17 more
2022Cancers13 citations Open access
Semantic Scholar
Time‐dependent changes in the seroprevalence of COVID‐19 in asymptomatic liver disease outpatients in an area in Japan undergoing a second wave of COVID‐19
G. Suda, K. Ogawa, M. Kimura, Osamu Maehara +13 more
2020Hepatology Research13 citations
Semantic Scholar
Serum FGF21 as a predictor of response to atezolizumab and bevacizumab in HCC
R. Kohya, G. Suda, M. Ohara, Shunichi Hosoda +30 more
2025JHEP Reports12 citations Open access
Semantic Scholar
Frequency and Characteristics of Overestimated Renal Function in Japanese Patients with Chronic Liver Disease and Its Relation to Sarcopenia
Sonoe Yoshida, G. Suda, M. Ohara, Qing-Jie Fu +17 more
2021Nutrients11 citations Open access
Semantic Scholar
Case Report: Hereditary Fibrosing Poikiloderma With Tendon Contractures, Myopathy, and Pulmonary Fibrosis (POIKTMP) Presenting With Liver Cirrhosis and Steroid-Responsive Interstitial Pneumonia
M. Takimoto-Sato, T. Miyauchi, Masaru Suzuki, H. Ujiie +20 more
2022Frontiers in Genetics10 citations Open access
Semantic Scholar
Changes in the estimated renal function after hepatitis C virus eradication with direct‐acting antiviral agents: Impact of changes in skeletal muscle mass
Yoshimasa Tokuchi, G. Suda, M. Kimura, Osamu Maehara +12 more
2021Journal of Viral Hepatitis10 citations
Semantic Scholar
Three-year overall survival in unresectable hepatocellular carcinoma treated with atezolizumab plus bevacizumab
M. Ohara, G. Suda, R. Kohya, Y. Yasui +34 more
2025Hepatology International8 citations
Semantic Scholar
Effects of nucleos(t)ide analogs on hepatitis B surface antigen reduction with interferon‐lambda 3 induction in chronic hepatitis B patients
M. Umemura, K. Ogawa, Kenichi Morikawa, Akinori Kubo +20 more
2022Hepatology Research8 citations
Semantic Scholar
Overestimated renal function in patients with liver cirrhosis predicts poor prognosis
Sonoe Yoshida, G. Suda, M. Ohara, M. Kimura +17 more
2022Hepatology Research7 citations
Semantic Scholar
The potential of soluble CD14 in discriminating nonalcoholic steatohepatitis from nonalcoholic fatty liver disease
Akihisa Nakamura, Koji Yamamoto, Rei Takeda, Ren Yamada +19 more
2022Hepatology Research7 citations
Semantic Scholar
Possible correlation between increased serum free carnitine levels and increased skeletal muscle mass following HCV eradication by direct acting antivirals
Yoshimasa Tokuchi, G. Suda, M. Kimura, Osamu Maehara +17 more
2021Scientific Reports7 citations Open access
Semantic Scholar
Association of proteinuria with improved prognosis in unresectable hepatocellular carcinoma treated with atezolizumab and bevacizumab, and the predictive role of serum vascular endothelial growth factor D levels: A multicenter retrospective study
Zi-Jian Yang, G. Suda, T. Sho, Osamu Maehara +19 more
2024Hepatology Research6 citations
Semantic Scholar
Incidence of post‐transplant hepatitis B virus reactivation with the use of kidneys from donors with resolved hepatitis B virus infection
Ren Yamada, Kenichi Morikawa, K. Hotta, D. Iwami +16 more
2022Journal of Viral Hepatitis6 citations
Semantic Scholar
Efficacy of rifaximin against covert hepatic encephalopathy and hyperammonemia in Japanese patients
M. Nakai, G. Suda, K. Ogawa, Sonoe Yoshida +10 more
2022PLoS ONE6 citations Open access
Semantic Scholar
Prospect of lenvatinib for unresectable hepatocellular carcinoma in the new era of systemic chemotherapy
T. Sho, Kenichi Morikawa, A. Kubo, Yoshimasa Tokuchi +9 more
2021World Journal of Gastrointestinal Oncology6 citations Open access
Semantic Scholar
Pre-sarcopenia and Mac-2 binding protein glycosylation isomer as predictors of recurrence and prognosis of early-stage hepatocellular carcinoma
M. Nakai, Kenichi Morikawa, Shunichi Hosoda, Sonoe Yoshida +9 more
2022World Journal of Hepatology5 citations Open access
Semantic Scholar
Baseline serum angiopoietin-2 and VEGF levels predict the deterioration of the liver functional reserve during lenvatinib treatment for hepatocellular carcinoma
T. Shigesawa, G. Suda, M. Kimura, Osamu Maehara +15 more
2021PLoS ONE5 citations Open access
Semantic Scholar
Durable response without recurrence to Tolvaptan improves long-term survival
M. Nakai, G. Suda, A. Kubo, Yoshimasa Tokuchi +12 more
2020Journal of gastroenterology5 citations
Semantic Scholar
Tenofovir alafenamide prevents HBV reactivation in anticancer/immunosuppression: 24-month multicentre prospective study.
G. Suda, M. Ohara, Masaru Baba, Yoshiya Yamamoto +25 more
2026Journal of Infection2 citations Open access
Semantic Scholar
The First Case of Hereditary Fibrosing Poikiloderma with Tendon Contractures, Myopathy, and Pulmonary Fibrosis (POIKTMP) Who Showed Efficacy of Corticosteroids for Pulmonary Involvement
M. Sato, Masanobu Suzuki, T. Ikari, T. Nakamura +18 more
20202 citations
Semantic Scholar
Neutrophil gelatinase-associated lipocalin predicts the efficacy of tolvaptan for ascites in patients with liver cirrhosis
M. Nakai, Kenichi Morikawa, Takashi Sasaki, R. Kohya +11 more
2023Journal of gastroenterology1 citations
Semantic Scholar
FRI-256 Durable response is associated with long-term survival even in patients with poor hepatic reserve after Atezolizumab plus Bevacizumab: a multicenter 3-year overall survival cohort with a 6-month landmark analysis
M. Ohara, G. Suda, R. Kohya, Y. Yasui +25 more
2026Journal of Hepatology0 citations
Semantic Scholar
Selective PPARα Modulator Pemafibrate Ameliorates Metabolic Dysfunction-Associated Steatotic Liver Disease Through Regulation of Leptin Signaling and Remodeling of Gut Microbiota
Koji Yamamoto, Masaru Baba, Akinori Kubo, Ren Yamada +9 more
2026International Journal of Molecular Sciences0 citations Open access
Semantic Scholar
Simplified monitoring of sofosbuvir/velpatasvir in Japanese patients with chronic hepatitis C based on a retrospective analysis of a prospective multicenter cohort
G. Suda, Masaru Baba, Yoshiya Yamamoto, Sonoe Yoshida +22 more
2025Scientific Reports0 citations Open access
Semantic Scholar
P-171 Lenvatinib in patients with unresectable hepatocellular carcinoma who do not meet REFLECT trial inclusion criteria
T. Sho, G. Suda, K. Ogawa, Takashi Kitagataya +8 more
20200 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

M. Nakai×39
Invite
M. Nakai — researcher profile on SciRah
T. Sho×39
Invite
T. Sho — researcher profile on SciRah
K. Ogawa×39
Invite
K. Ogawa — researcher profile on SciRah
Takashi Kitagataya×38
Invite
Takashi Kitagataya — researcher profile on SciRah

×37

Invite

G. Suda — researcher profile on SciRah

Invite

M. Ohara — researcher profile on SciRah

Kenichi Morikawa×29

Invite

Kenichi Morikawa — researcher profile on SciRah

N. Sakamoto×28

Invite

N. Sakamoto — researcher profile on SciRah

M. Natsuizaka×27

Invite

M. Natsuizaka — researcher profile on SciRah

Kazuharu Suzuki×26

Invite

Kazuharu Suzuki — researcher profile on SciRah

Osamu Maehara×24

Invite

Osamu Maehara — researcher profile on SciRah

Yoshimasa Tokuchi×24

Invite

Yoshimasa Tokuchi — researcher profile on SciRah